Cross-protective immunity to Gram-negative bacilli: studies with core glycolipid of Salmonella minnesota and antigens of Streptococcus pneumoniae
- PMID: 19538
- DOI: 10.1093/infdis/136.supplement.s174
Cross-protective immunity to Gram-negative bacilli: studies with core glycolipid of Salmonella minnesota and antigens of Streptococcus pneumoniae
Abstract
Two immunoprophylactic approaches to the control of infections caused by gramnegative bacilli were evaluated by study of experimental infections in animals. The core glycolipid antigen derived from the Re mutant of Salmonella minnesota R595 is shared by virtually all enteric bacteria, and immunization with this endotoxin protects against the hemodynamic sequelae of bacterial infection and pyrexia without enhancing intravascular clearance of bacteria. The degree of protection afforded by active and passive immunization with core glycolipid was significantly less than that conferred by type-specific immunization. Escherichia coli and Klebsiella pneumoniae share capsular antigens with some strains of Streptococcus pneumoniae; by the mechanism of enhanced opsonization, antibodies to S. pneumoniae may cross-protect against infection with E. coli or K. pneumoniae.
Similar articles
-
Functional role of antibody against "core" glycolipid of Enterobacteriaceae.J Clin Invest. 1975 Oct;56(4):850-61. doi: 10.1172/JCI108164. J Clin Invest. 1975. PMID: 1099119 Free PMC article.
-
Cross-reactive antigens: their potential for immunization-induced immunity to Gram-negative bacteria.J Infect Dis. 1977 Aug;136 Suppl:S161-6. doi: 10.1093/infdis/136.supplement.s161. J Infect Dis. 1977. PMID: 330775 Review.
-
Relationship of structure to function in bacterial endotoxins: serologically cross-reactive components and their effect on protection of mice against some gram-negative infections.J Gen Microbiol. 1976 May;94(1):107-16. doi: 10.1099/00221287-94-1-107. J Gen Microbiol. 1976. PMID: 778329
-
Escherichia coli antibodies in opsonisation and protection against infection.J Med Microbiol. 1981 Nov;14(4):381-9. doi: 10.1099/00222615-14-4-381. J Med Microbiol. 1981. PMID: 7031250
-
Potential use of shared antigens for immunization against gram-negative bacillary infections.Prog Clin Biol Res. 1980;47:107-17. Prog Clin Biol Res. 1980. PMID: 6163155 Review.
Cited by
-
Passive immunization against Pseudomonas with a ribosomal vaccine-induced immune serum and immunoglobulin fractions.Infect Immun. 1979 Feb;23(2):509-21. doi: 10.1128/iai.23.2.509-521.1979. Infect Immun. 1979. PMID: 106013 Free PMC article.
-
Immunotherapeutic advances in the treatment of gram-negative bacterial sepsis.World J Surg. 1987 Apr;11(2):233-40. doi: 10.1007/BF01656407. World J Surg. 1987. PMID: 3296482 Review. No abstract available.
-
Radioimmunoassay and opsonic antibody responses to pneumococcal capsular polysaccharide vaccine in serum and ascitic fluid of cirrhotic patients.J Clin Microbiol. 1983 Jul;18(1):154-9. doi: 10.1128/jcm.18.1.154-159.1983. J Clin Microbiol. 1983. PMID: 6885986 Free PMC article.
-
Immunization against bacteria- and endotoxin-induced hypotension.Infect Immun. 1981 Jun;32(3):1093-9. doi: 10.1128/iai.32.3.1093-1099.1981. Infect Immun. 1981. PMID: 7251158 Free PMC article.
-
Use of mucin and hemoglobin in experimental murine gram-negative bacteremia enhances the immunoprotective action of antibodies reactive with the lipopolysaccharide core region.Antonie Van Leeuwenhoek. 1986;52(6):537-42. doi: 10.1007/BF00423414. Antonie Van Leeuwenhoek. 1986. PMID: 3545072
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources